HomeNewsTrendsHealthContinuing COVID-19 outbreaks across India attributable to Delta variant: INSACOG

Continuing COVID-19 outbreaks across India attributable to Delta variant: INSACOG

Of the 30,230 samples of Variants of Concern and Variants of Interest sequenced by the INSACOG, 20,324 were of Delta.

August 20, 2021 / 14:59 IST

Continuing COVID-19 outbreaks across India are attributable to the Delta variant, a susceptible population and reduced vaccine effectiveness in blocking transmission, the INSACOG, a genome sequencing government consortium of laboratories, has said.

However, vaccination continues to be very effective in reducing severe disease and death, and public health measures to reduce transmission and inoculation remain critical, the INSACOG stressed in its latest bulletin dated August 16.

As of now sequencing of vaccination breakthroughs in India is also showing a very high proportion of Delta variant, the INSACOG said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Of the 30,230 samples of Variants of Concern and Variants of Interest sequenced by the INSACOG, 20,324 were of Delta.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In India, new cases of AY.1, AY.2, AY.3 (Delta Plus) are being seen in July samples from Maharashtra at a frequency of about 1 per cent. However, at this time none of these sub-lineages has been found to have a growth advantage over the Delta parent lineage, it noted.

According to INSACOG (the Indian SARS-CoV2 Genomics Consortium), 61 samples of Delta Plus variants have been detected in the country so far.

"Delta variant is the major VOC in India at this time. Continuing outbreaks across India are attributable to Delta, a susceptible population, reduced vaccine effectiveness in blocking transmission, and opportunities for transmission," the INSACOG said.

Daily coronavirus cases have seen a significant plunge since the second wave which peaked in May.

The active cases have declined to 3,63,605, the lowest in 150 days, and comprise 1.12 per cent of the total infections, the lowest since March 2020, the Health Ministry said on Friday. Over 57 crore jabs have been administered in the country so far, the Health Ministry added.

The R Value, or the Reproduction rate in the country has also dipped to 0.89 from August 14-16. But country continues to post over 25,000 cases everyday.

There has been a concern whether an increasing vaccination breakthroughs in India are because of a new variant, the INSACOG said.

It also cited an example of the UK. With a population of about 6.7 crore, the UK has reported about 18 lakh cases and 1.2 lakh vaccination breakthroughs with Delta since April 2021.

"Thus, vaccination breakthroughs are common during Delta outbreaks and are expected in India as well,” it said.

"As of now sequencing of vaccination breakthroughs in India is also showing a very high proportion of Delta variant. Investigations for any new variants are ongoing," it added.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Aug 20, 2021 02:59 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347